Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Bernard La Scola and Julien Andreani.
Bernard La Scola
Connection Strength
0.725
Julien Andreani
  1. Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards. Eur J Clin Microbiol Infect Dis. 2020 Jun; 39(6):1059-1061.
    View in: PubMed
    Score: 0.220
  2. In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect. Microb Pathog. 2020 Aug; 145:104228.
    View in: PubMed
    Score: 0.220
  3. In Vitro Evaluation of the Antiviral Activity of Methylene Blue Alone or in Combination against SARS-CoV-2. J Clin Med. 2021 Jul 06; 10(14).
    View in: PubMed
    Score: 0.060
  4. In Vitro Antiviral Activity of Doxycycline against SARS-CoV-2. Molecules. 2020 Oct 31; 25(21).
    View in: PubMed
    Score: 0.057
  5. Methylene blue inhibits replication of SARS-CoV-2 in vitro. Int J Antimicrob Agents. 2020 Dec; 56(6):106202.
    View in: PubMed
    Score: 0.057
  6. Antimalarial drugs inhibit the replication of SARS-CoV-2: An in vitro evaluation. Travel Med Infect Dis. 2020 Sep - Oct; 37:101873.
    View in: PubMed
    Score: 0.056
  7. Antimalarial artemisinin-based combination therapies (ACT) and COVID-19 in Africa: In vitro inhibition of SARS-CoV-2 replication by mefloquine-artesunate. Int J Infect Dis. 2020 Oct; 99:437-440.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.